TUMIATTI, VINCENZO

TUMIATTI, VINCENZO

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

TUMIATTI, VINCENZO 

DIPARTIMENTO DI SCIENZE PER LA QUALITA' DELLA VITA 

Docenti di ruolo di Ia fascia 

Pubblicazioni

Risultati 1 - 20 di 89 (tempo di esecuzione: 0.001 secondi).

TitoloAutore(i)AnnoPeriodicoEditoreTipoFile
1A rational design of new multi-target-directed-ligands for the treatment of Alzheimer's diseaseTumiatti V.2008s.n4.01 Contributo in Atti di convegno-
2Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitorsDE SIMONE, Angela; Fiori, Jessica; Naldi, Marina; D'Urzo, Annalisa; Tumiatti, Vincenzo; Milelli, ...Andrea; Andrisano, Vincenza2017JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS1.01 Articolo in rivista-
3Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid ActivitiesBolognesi ML; Bartolini M ; Mancini F ; Chiriano G ; Ceccarini L; Rosini M; Milelli A; Tumiatti V...; Andrisano V; Melchiorre C2010CHEMMEDCHEM1.01 Articolo in rivista-
4Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate.Tarozzi, A; Marchetti, C; Nicolini, B; D'Amico, M; Ticchi, N; Pruccoli, L; Tumiatti, V; Simoni, E...; Lodola, A; Mor, M; Milelli, A; Minarini, A.2016EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
5Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507)De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martin...i C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A.2019ACS MEDICINAL CHEMISTRY LETTERS1.01 Articolo in rivista-
6Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.Minarini A.; Milelli A.; Tumiatti V.; Rosini M.; Simoni E.; Bolognesi M.L.; Andrisano V.; Bartoli...ni M.; Motori E.; Angeloni C.; Hrelia S.2012NEUROPHARMACOLOGY1.01 Articolo in rivista-
7Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatmentA. Minarini; A. Milelli; V. Tumiatti; E. Simoni; M. L. Bolognesi; V. Andrisano; M. Bartolini; E. ...Motori; C. Angeloni ; S. Hrelia; C.Melchiorre20112011 Università del Salento – Coordinamento SIBA-4.02 Riassunto (Abstract)-
8Cytotoxicity of methoctramine and methoctramine-related polyamines.Zini M.; Passariello C.L.; Gottardi D.; Cetrullo S.; Flamigni F.; Pignatti C.; Minarini A.; Tumia...tti V.; Milelli A.; Melchiorre C.; Stefanelli C.2009CHEMICO-BIOLOGICAL INTERACTIONS1.01 Articolo in rivista-
9Cytotoxicity of Methoctramine and related Spermine analoguesA. Minarini; V. Tumiatti; F. Flamigni; M. Zini; C. Stefanelli2007CSU Università degli Studi di Roma La Sapienza4.02 Riassunto (Abstract)-
10Cytotoxicity of methoctramine-related polyaminesV. Tumiatti; A. Minarini; A. Milelli; C. Cappadone; M. Zini; C. Stefanelli2011SN4.02 Riassunto (Abstract)-
11Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionalityA. Minarini; A. Milelli; V. Tumiatti; L. Ferruzzi; M. R. Marton; E. Turrini; P. Hrelia; C. Fimognari2012EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
12DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SUSTITUTED NAPHTHALENE IMIDES AND DIIMIDES AS ANTICANCER AGENTTumiatti V; Milelli A ; Minarini A; Micco M; Gasperi-Campani A; Roncuzzi L; Baiocchi D; Marinello... J; Capranico G; Zini M; Stefanelli C; Melchiorre C2009JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
13Design, Synthesis, and biological evaluation of naphtalene diimides derivatives as anticancer agentA. Milelli; A. Minarini; C. Melchiorre; M. Micco; E. Simoni; G. Zuccari; L. Raffaghello; C. Stefa...nelli; M. Zini; V. Tumiatti2010s.n4.02 Riassunto (Abstract)-
14Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and a perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinicsA. Minarini; G. Marucci; C. Bellucci; G. Giorgi; V. Tumiatti; M. L. Bolognesi; R. Matera; M. Rosi...ni; C. Melchiorre2008BIOORGANIC & MEDICINAL CHEMISTRY1.01 Articolo in rivista-
15Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compoundsA. Antonello; P. Hrelia; A. Leonardi; G. Marucci; M. Rosini; A. Tarozzi; V. Tumiatti; C. Melchiorre2005JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
16Design, synthesis, and biological evaluation of substituted naphtalene imides and diimides as anticancer agentsV. Tumiatti; A. Milelli; A. Minarini; M. Micco; A. Gasperi Campani; L. Roncuzzi; D. Baiocchi; M. ...Zini; C. Stefanelli; C. Melchiorre2009DRUGS OF THE FUTURE4.02 Riassunto (Abstract)-
17Discovery of multipotent drugs for the teratment of Alzheimer's diseaseRosini M.; Andrisano V.; Bartolini M.; Bolognesi M.L.; Cavalli A.; Minarini A.; Recanatini M.; Tu...miatti V.; Melchiorre C.2005SCIENTIA PHARMACEUTICA4.02 Riassunto (Abstract)-
18Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Pe...tralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A.2019ACS MEDICINAL CHEMISTRY LETTERS1.01 Articolo in rivista-
19Effect of polyamines on the nicotinic ACh receptorEwa Nurowska, Vincenzo Tumiatti, Beata Dworakowska2018JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH1.01 Articolo in rivista-
20Evaluation of the inhibitory potency of a new series of AChE-inhibitors by using a monolithic AChE-micro-IMERM. Bartolini; V. Tumiatti; V. Andrisano2004s.n4.02 Riassunto (Abstract)-
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021